Paying users zone. Data is covered by .

  • Get to Allergan PLC for $13.99, or

  • get to whole website for at least 3 months from $49.99.

 

$13.99

Income Statement

Difficulty: Beginner

Allergan PLC, Consolidated Income Statement

USD $ in thousands

 
12 months ended Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net revenues
Cost of sales, excludes amortization and impairment of acquired intangibles including product rights
Gross profit
Research and development
Selling and marketing
General and administrative
Amortization
Goodwill impairments
In-process research and development impairments
Loss on assets held for sale
Asset sales and impairments, net
Operating loss
Interest income
Interest expense
Teva Share Activity
Debt extinguishment costs as part of the debt tender offer
Debt extinguishment other
Other-than-temporary impairments
Dividend income
Naurex recovery
Forward sale of Teva shares
Pfizer termination fee, Allergan plc only
Bridge loan commitment fee
Interest rate lock
Gain (loss) on sale of assets
Other
Other income (expense), net
Loss before income taxes and noncontrolling interest
Provision (benefit) for income taxes
Net loss from continuing operations, net of tax
Income (loss) from discontinued operations, net of tax
Net income (loss)
(Income) loss attributable to noncontrolling interest
Net income (loss) attributable to shareholders
Dividends on preferred shares
Net income (loss) attributable to ordinary shareholders
Source: Allergan PLC, Annual Reports
Item Description The company
Net revenues Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Allergan PLC's net revenues declined from 2015 to 2016 but then increased from 2016 to 2017 exceeding 2015 level.
Operating loss The net result for the period of deducting operating expenses from operating revenues. Allergan PLC's operating loss increased from 2015 to 2016 but then declined significantly from 2016 to 2017.
Loss before income taxes and noncontrolling interest Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Allergan PLC's loss before income taxes and noncontrolling interest increased from 2015 to 2016 but then declined significantly from 2016 to 2017.
Net loss from continuing operations, net of tax This represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Allergan PLC's net loss from continuing operations, net of tax increased from 2015 to 2016 but then declined significantly from 2016 to 2017.
Net income (loss) The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Allergan PLC's net income (loss) increased from 2015 to 2016 but then declined significantly from 2016 to 2017.
Net income (loss) attributable to shareholders The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Allergan PLC's net income (loss) attributable to shareholders increased from 2015 to 2016 but then declined significantly from 2016 to 2017.

Top